Novel imidazopyrimidine compound and uses thereof
AssigneesChildren's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
InventorsDavid J. Dowling, Ofer Levy, Dheeraj Soni, David A. Scott
Life of this patent
Estimating the term…
Loading patent…
AssigneesChildren's Medical Center Corporation, Dana-Farber Cancer Institute, Inc.
InventorsDavid J. Dowling, Ofer Levy, Dheeraj Soni, David A. Scott
Estimating the term…
The present disclosure provides Compound (1), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Compound (1) is used as an enhancer and/or modifier of an immune response (e.g., innate and/or adaptive immune response), and is useful in treating and/or preventing a disease, as an adjuvant in a vaccine for a disease, (e.g., a proliferative disease, an inflammatory disease, an autoimmune disease, an infectious disease, an allergy, a fibrotic disease, a cardiovascular disease, a graft rejection, graft-versus-host disease, chronic disease, or addiction), or as stand alone anti-infective or immune response modifying agents. Also provided in the present disclosure are vaccines, pharmaceutical compositions, kits, methods, and uses including or using Compound (1).
A compound of formula:
A compound of formula:
A method of treating a disease in a subject in need thereof, the method comprising administering the compound of any of claims 1-3, the pharmaceutical composition of claim 4 or 5, the composition of any of claims 40-63, or the vaccine of any of claims 64-67.
A method of enhancing an immune response in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the compound of any of claims 1-3, the pharmaceutical composition of claim 4 or 5, the composition of any of claims 40-63, or the vaccine of any of claims 64-67.
A kit comprising the compound of any of claims 1-3, the pharmaceutical composition of claim 4 or 5, the composition of any of claims 40-63, or the vaccine of any of claims 64-67;
The composition of claim 45, wherein the microbial pathogen is a bacterium, mycobacterium, fungus, virus, parasite, or prion.
Dependencies are inferred from the claim text.